Pay in 4 interest-free payments of $6.52 Learn more
Ships within 48 hours · Estimated delivery Oct 17 - Oct 22
is tirzepatide cheaper than semaglutide vs Tirzepatide: Head-to-Head for Weight Loss & Diabetes ENDOCRINOLOGIA Program:Monthly Retatrutide: What It Is
Retatrutide: What It Is & How This New Drug Works
Recently, a non-steroidal MRA, finerenone, has shown positive results in patients with HFpEF [10], and although it has not yet been studied in patients with obesity, a post-hoc analysis of the TOPCAT trial, which was based on another MRA, spironolactone, showed that spironolactone improved clinical outcomes in patients with obesity, suggesting that finerenone may be a promising treatment for obesity-related HFpEF [101,102]
ENDOCRINOLOGIA
Program:Monthly
2012 Mar;166(3):477-85
